New Orleans Law Firm Reminds Investors of Filing Deadline in Cassava Sciences, Inc. Securities Class Action Lawsuit
February 6, 2025
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., are reminding investors about the upcoming deadline to file lead plaintiff applications in a securities class action lawsuit against Cassava Sciences, Inc.
Investors who purchased Cassava Sciences, Inc. (NASDAQ: SAVA) securities between February 7, 2024 and November 24, 2024, inclusive, have until February 10, 2025 to take action. The lawsuit alleges that during the Class Period, Cassava Sciences made false and/or misleading statements and/or failed to disclose information regarding the Company’s business, operations, and prospects.
As an investor, it is crucial to be aware of your rights and options in situations like this. By filing a lead plaintiff application, you may participate in the lawsuit to seek recovery of your losses.
For more information on how to file for lead plaintiff status or to learn more about the allegations against Cassava Sciences, Inc., please contact Kahn Swick & Foti, LLC. Don’t miss the deadline to take action and protect your investment.
Impact on Me
As an investor who purchased Cassava Sciences, Inc. securities during the specified Class Period, it is important for me to be aware of the upcoming deadline to file for lead plaintiff status in the securities class action lawsuit. By taking action and participating in the lawsuit, I may have the opportunity to seek recovery of any losses incurred as a result of the alleged false and/or misleading statements made by the Company. It is crucial for me to understand my rights and options in this situation to protect my investment.
Impact on the World
The securities class action lawsuit against Cassava Sciences, Inc. has the potential to have a significant impact on the financial market and investor confidence. Allegations of false and/or misleading statements made by a company can not only lead to financial losses for investors but also erode trust in the integrity of the market. The outcome of this lawsuit may set a precedent for how similar cases are handled in the future and could influence corporate transparency and accountability practices globally.
Conclusion
Investors who purchased Cassava Sciences, Inc. securities between February 7, 2024 and November 24, 2024, are reminded to take action and file for lead plaintiff status in the securities class action lawsuit before the upcoming deadline on February 10, 2025. By participating in the lawsuit, investors have the opportunity to seek recovery of their losses and hold the Company accountable for any alleged false and/or misleading statements. It is crucial for investors to be informed of their rights and options in situations like this to protect their investments and maintain trust in the financial market.
